Bortezomib 3.5mg Injection: Effective Treatment for Cancer

Bortezest 3.5mg Injection

Description

• Class: Proteasome inhibitors.
• Active ingredient: Bortezomib.

Uses

• Treatment of multiple myeloma.
• Treatment of mantle cell lymphoma.

Administration

• Administered intravenously in your vein or subcutaneously under the skin.
• Should be given by a qualified healthcare professional experienced in the use of cytotoxic medications.
• Do not self-administer.

Important Information

• Store unopened vials in the refrigerator (2 °C – 8 °C) and protect them from light.
• Keep this medicine out of sight and reach of children.
• Inform your doctor about any prescribed medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products that you are taking or have taken before the treatment.

Contraindications

• Do not use this medication if you have severe lung or heart problems.
• Before starting treatment, let your physician know if you are suffering from neuropathy (nerves malfunction), cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumor lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders.

Pregnancy and Breastfeeding

• Unsafe to use during pregnancy unless clearly necessary.
• Unsafe to use during breastfeeding.

Side Effects

• Serious: muscle cramps, confusion, visual disturbances, seizures, headache, breathlessness, swelling of feet, changes in heartbeat, high blood pressure, fainting and tiredness, cough and chest tightness.
• Common: pneumonia, loss of appetite, sensitivity, tingling and burning sensation of the skin, nausea, vomiting, diarrhea, mouth ulcers, constipation, muscle and bone pain, hair loss, fever, reduction in blood cell count, reduced kidney function, shivering, infections, itching and redness, dehydration, stomach problems, difficulty sleeping, anxiety, mood swings, depressed mood.

Safety Advice

• Avoid driving or using machinery if you experience side effects like fainting, dizziness, tiredness, or blurred vision.
• Do not consume alcohol with this medication.
• Pregnant women should not handle this Injection as it contains cytotoxic agents. Using gloves and protective clothing is recommended to prevent skin contact.

FAQs

1. What is Bortezest 3.5mg Injection used for? Bortezest 3.5mg Injection is mainly indicated to treat mantle cell lymphoma and multiple myeloma.

2. Can I drive while taking Bortezest 3.5mg Injection? Bortezest 3.5mg Injection may cause dizziness, tiredness, fainting, or blurred vision. Hence, avoid driving and operating heavy machines while this Injection.

3. How is Bortezest 3.5mg Injection given? Bortezest 3.5mg Injection is administered intravenously in your vein or subcutaneously under the skin by a doctor in a medical facility.

4. Is it safe to handle Bortezest 3.5mg Injection while pregnant? No, Pregnant women should not handle Bortezest 3.5mg Injection as it contains cytotoxic agents. Using gloves and protective clothing is recommended to prevent skin contact.

5. What class of chemo is Bortezest 3.5mg Injection? Bortezest 3.5mg Injection is a targeted therapy that belongs to the class of medicines called proteasome inhibitors.

6. Can I take Bortezest 3.5mg Injection when I am pregnant? Avoid taking Bortezest 3.5mg Injection if you are pregnant, as it can cause harmful effects on the unborn baby. Females should use effective birth control methods during treatment and at least three months after treatment.

7. I am suffering from a Hepatitis infection. Can I take Bortezest 3.5mg Injection? Bortezest 3.5mg Injection should not be used in patients with hepatitis infection because they might have a repeated attack of hepatitis, which can be fatal. If you have a history of hepatitis B infection, your doctor will carefully check you for signs of active hepatitis B.

Fact Box

• Molecule name: Bortezomib.
• Therapeutic class: Antineoplastics agents.
• Pharmacological class: Proteasome inhibitor.
• Indications:
  • Multiple myeloma.
  • Mantle cell lymphoma.

Tags: Bortezest, Injection, Medicine, 3.5mg, MedicalProduct, Drug, Oncology, Chemotherapy